MX9700020A - Cyclic benzazepine urea derivatives with aggregation-inhibiting effect. - Google Patents
Cyclic benzazepine urea derivatives with aggregation-inhibiting effect.Info
- Publication number
- MX9700020A MX9700020A MX9700020A MX9700020A MX9700020A MX 9700020 A MX9700020 A MX 9700020A MX 9700020 A MX9700020 A MX 9700020A MX 9700020 A MX9700020 A MX 9700020A MX 9700020 A MX9700020 A MX 9700020A
- Authority
- MX
- Mexico
- Prior art keywords
- aggregation
- urea derivatives
- cyclic
- benzazepine
- inhibiting effect
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Cyclic urea derivatives having the general formula (I), in which R1 to R9, Ra, Rb, A, D, E and F have the definitions given in the first claim, their tautomers, their stereoisomers, including their mixtures and their salts, in particular their physiologically acceptable salts with inorganic or organic acids or bases, have valuable pharmacological and other properties, preferably aggregation-inhibiting effects. Also disclosed are medicaments containing said compounds, their use and a process for producing the same.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4429079A DE4429079A1 (en) | 1994-08-17 | 1994-08-17 | Cyclic urea derivatives, pharmaceutical compositions containing them and processes for their preparation |
PCT/EP1995/003233 WO1996005194A1 (en) | 1994-08-17 | 1995-08-16 | Cyclic benzazepine urea derivatives with aggregation-inhibiting effect |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9700020A true MX9700020A (en) | 1997-12-31 |
Family
ID=6525854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9700020A MX9700020A (en) | 1994-08-17 | 1995-08-16 | Cyclic benzazepine urea derivatives with aggregation-inhibiting effect. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0777667A1 (en) |
JP (1) | JPH10504298A (en) |
AU (1) | AU3345995A (en) |
CA (1) | CA2197789A1 (en) |
CO (1) | CO4410324A1 (en) |
DE (1) | DE4429079A1 (en) |
IL (1) | IL114980A0 (en) |
MX (1) | MX9700020A (en) |
WO (1) | WO1996005194A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19624069A1 (en) * | 1996-06-17 | 1997-12-18 | Thomae Gmbh Dr K | Benzazepine derivatives, pharmaceutical compositions containing them and methods for their preparation |
PE20020689A1 (en) | 2000-11-17 | 2002-08-03 | Upjohn Co | OXAZOLIDINONES WITH A HETEROCYCLE OF 6 OR 7 MEMBERS UNITED WITH ANNULAR LINK TO BENZENE |
US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
BR0317483A (en) | 2002-12-20 | 2005-11-16 | Glaxo Group Ltd | Benzodiazepine derivatives for the treatment of neurological disorders |
CN1805939B (en) | 2003-06-17 | 2010-10-13 | 艾尼纳制药公司 | Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
HUE028976T2 (en) | 2003-06-17 | 2017-02-28 | Arena Pharm Inc | 8-Chloro-1 -methyl-2,3,4,5-tetrahydro-1 H-3benzazapine Hydrochloride |
GB0329214D0 (en) * | 2003-12-17 | 2004-01-21 | Glaxo Group Ltd | Novel compounds |
GB0405628D0 (en) * | 2004-03-12 | 2004-04-21 | Glaxo Group Ltd | Novel compounds |
DK1838677T3 (en) | 2004-12-21 | 2010-01-11 | Arena Pharm Inc | Crystalline forms of (R) -8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride |
SI1833473T1 (en) | 2004-12-23 | 2010-01-29 | Arena Pharm Inc | 5ht2c receptor modulator compositions and methods of use |
JP5199997B2 (en) | 2006-04-03 | 2013-05-15 | アリーナ ファーマシューティカルズ, インコーポレイテッド | Process for preparing 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and related intermediates |
SG177128A1 (en) | 2006-12-05 | 2012-01-30 | Arena Pharm Inc | Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
US8822727B2 (en) | 2008-03-04 | 2014-09-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
EP2443080A2 (en) | 2009-06-18 | 2012-04-25 | Arena Pharmaceuticals, Inc. | Process for the preparation of 5-ht2c receptor agonists |
KR20130112848A (en) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | Processes for the preparation of 5-ht2c receptor agonists |
CN103347523A (en) | 2010-09-01 | 2013-10-09 | 艾尼纳制药公司 | Administration of lorcaserin to individual with renal impairment |
CA2808904A1 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Non-hygroscopic salts of 5-ht2c agonists |
EP2611782A1 (en) | 2010-09-01 | 2013-07-10 | Arena Pharmaceuticals, Inc. | Salts of lorcaserin with optically active acids |
EP3485878A1 (en) | 2010-09-01 | 2019-05-22 | Arena Pharmaceuticals, Inc. | Modified-release dosage forms of 5-ht2c agonists useful for weight management |
MY181736A (en) | 2012-10-09 | 2021-01-05 | Arena Pharm Inc | Method of weight management |
US10853589B2 (en) | 2014-04-25 | 2020-12-01 | Mentor Acquisition One, Llc | Language translation with head-worn computing |
CA3080959A1 (en) * | 2017-11-02 | 2019-05-09 | Calico Life Sciences Llc | Modulators of the integrated stress pathway |
BR112020008834A2 (en) | 2017-11-02 | 2020-12-22 | Calico Life Sciences Llc | MODULATORS OF THE INTEGRATED STRESS ROUTE |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4107857A1 (en) * | 1991-03-12 | 1992-09-17 | Thomae Gmbh Dr K | CYCLIC UREA DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
DE4127404A1 (en) * | 1991-08-19 | 1993-02-25 | Thomae Gmbh Dr K | CYCLIC IMINODERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
DE4332168A1 (en) * | 1993-02-22 | 1995-03-23 | Thomae Gmbh Dr K | Cyclic derivatives, pharmaceutical compositions containing these compounds and process for their preparation |
-
1994
- 1994-08-17 DE DE4429079A patent/DE4429079A1/en not_active Withdrawn
-
1995
- 1995-08-16 AU AU33459/95A patent/AU3345995A/en not_active Abandoned
- 1995-08-16 EP EP95929874A patent/EP0777667A1/en not_active Withdrawn
- 1995-08-16 WO PCT/EP1995/003233 patent/WO1996005194A1/en not_active Application Discontinuation
- 1995-08-16 CO CO95036792A patent/CO4410324A1/en unknown
- 1995-08-16 MX MX9700020A patent/MX9700020A/en unknown
- 1995-08-16 CA CA002197789A patent/CA2197789A1/en not_active Abandoned
- 1995-08-16 JP JP8507030A patent/JPH10504298A/en not_active Ceased
- 1995-08-17 IL IL11498095A patent/IL114980A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CO4410324A1 (en) | 1997-01-09 |
IL114980A0 (en) | 1995-12-08 |
WO1996005194A1 (en) | 1996-02-22 |
EP0777667A1 (en) | 1997-06-11 |
AU3345995A (en) | 1996-03-07 |
CA2197789A1 (en) | 1996-02-22 |
JPH10504298A (en) | 1998-04-28 |
DE4429079A1 (en) | 1996-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9700020A (en) | Cyclic benzazepine urea derivatives with aggregation-inhibiting effect. | |
BG101582A (en) | Piperazine derivatives, medicaments containing the same, their use and process for preparing the same | |
NO933248L (en) | Cyclic urea derivatives, drugs containing these compounds, and process for their preparation | |
TW226377B (en) | ||
PL298717A1 (en) | Cyclic imine derivatives, method of obtaining them and therapeutic agents containing such compounds | |
MX9803954A (en) | Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them. | |
BG105111A (en) | Benzimidazoles, production thereof and use thereof as medicaments | |
MX9605128A (en) | Neurokinine (tachykinine) antagonists. | |
NO923466L (en) | Heterocyclic Compounds with 5 Sections, PROCEDURE PREPARATION, AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS | |
NO934501L (en) | Carboxylic acid derivatives, drugs containing these compounds, and process for their preparation | |
HK1008742A1 (en) | Cyclic imino derivatives process for their preparation and drugs containing them | |
TW281675B (en) | ||
WO2000008014A8 (en) | Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect | |
YU50002A (en) | Substituted piperidines, medicaments containing these compounds,and methods for the production thereof | |
YU30902A (en) | Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof | |
NZ325259A (en) | Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments | |
YU3701A (en) | Substituted phenylamidines with antithrombotic action | |
GR3036023T3 (en) | Substituted phenyl amidines, medicaments containing these compounds and process for producing them | |
BG105326A (en) | Novel benzoylguanadine derivatives with advantageous properties, method for producing them and their use in the production of medicaments | |
MX9804752A (en) | Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments. | |
MX9803556A (en) | Amino acid derivatives, medicaments containing said compounds and methods of producing them. | |
MX9803557A (en) | Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds. | |
WO1995022544A3 (en) | Substituted 1,3,8-triaza-spiro(4,5)-decan-4-one derivatives useful as preliminary stages in the production of pharmaceuticals | |
WO2000018732A3 (en) | Disubstituted pyrrolidinones, medicaments containing these compounds, their use and the production thereof | |
MX9802988A (en) | 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them. |